BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24673475)

  • 1. Postprandial lipemia as a cardiometabolic risk factor.
    Pirillo A; Norata GD; Catapano AL
    Curr Med Res Opin; 2014 Aug; 30(8):1489-503. PubMed ID: 24673475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
    Toth PP
    Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipemia and cardiovascular disease.
    Hyson D; Rutledge JC; Berglund L
    Curr Atheroscler Rep; 2003 Nov; 5(6):437-44. PubMed ID: 14525676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.
    Chan DC; Pang J; Romic G; Watts GF
    Curr Atheroscler Rep; 2013 Mar; 15(3):309. PubMed ID: 23345190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.
    Eleftheriadou I; Grigoropoulou P; Katsilambros N; Tentolouris N
    Curr Diabetes Rev; 2008 Nov; 4(4):340-56. PubMed ID: 18991602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.
    Funatsu T; Kakuta H; Takasu T; Noguchi M; Suzuki M; Miyata K
    Metabolism; 2003 May; 52(5):609-15. PubMed ID: 12759892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipemia associates with liver fat content.
    Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial hyperlipidemia as a potential residual risk factor.
    Nakamura K; Miyoshi T; Yunoki K; Ito H
    J Cardiol; 2016 Apr; 67(4):335-9. PubMed ID: 26744235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dyslipidemia in patients with chronic kidney disease.
    Marino A; Tannock LR
    Postgrad Med; 2013 Jul; 125(4):28-37. PubMed ID: 23842535
    [No Abstract]   [Full Text] [Related]  

  • 12. Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.
    Matikainen N; Taskinen MR; Stennabb S; Lundbom N; Hakkarainen A; Vaaralahti K; Raivio T
    Eur J Endocrinol; 2012 Mar; 166(3):487-92. PubMed ID: 22190000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.
    Kolovou GD; Mikhailidis DP; Kovar J; Lairon D; Nordestgaard BG; Ooi TC; Perez-Martinez P; Bilianou H; Anagnostopoulou K; Panotopoulos G
    Curr Vasc Pharmacol; 2011 May; 9(3):258-70. PubMed ID: 21314632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial hypertriglyceridemia as a coronary risk factor.
    Borén J; Matikainen N; Adiels M; Taskinen MR
    Clin Chim Acta; 2014 Apr; 431():131-42. PubMed ID: 24508990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Dietary Glycemic Index and Glycemic Load on Postprandial Lipid Kinetics, Dyslipidemia and Cardiovascular Risk.
    Lambadiari V; Korakas E; Tsimihodimos V
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial VLDL-TG metabolism in type 2 diabetes.
    Søndergaard E; Johansen RF; Jensen MD; Nielsen S
    Metabolism; 2017 Oct; 75():25-35. PubMed ID: 28964326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial Hyperlipidemia and Remnant Lipoproteins.
    Masuda D; Yamashita S
    J Atheroscler Thromb; 2017 Feb; 24(2):95-109. PubMed ID: 27829582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial lipid metabolism in diabetes.
    Mero N; Syvänne M; Taskinen MR
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S53-5. PubMed ID: 9888643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
    Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.